Molina Healthcare Inc (MOH)
Official siteHEALTHCARE • HEALTHCARE PLANS • NYSE
Market Cap: $10.89B
Last updated: Nov 17, 2026 at 11:06 AM ET
Molina Healthcare Inc (MOH) Financials: Revenue, Profit and Cash Flow
Molina Healthcare reported revenue of $45.43B for the fiscal year ended Dec 31, 2025, up 11.7% from the year before. That year, net income was $472.00M with a net margin of 1.0%, operating cash flow was -$535.00M and free cash flow was -$636.00M. The quarter ended Sep 30, 2026 had revenue of $11.08B and net income of $38.00M.
Revenue and Margins
The operating margin was 1.7% in the fiscal year ended Dec 2025. Over the 9 years to Dec 2025, revenue grew from $17.78B, a compound annual rate of 11.0%.
| Fiscal year | Revenue | Growth | Gross margin | Operating margin | Net margin |
|---|---|---|---|---|---|
| Dec 2025 | $45.43B | +11.7% | 13.1% | 1.7% | 1.0% |
| Dec 2024 | $40.65B | +19.3% | 15.3% | 4.2% | 2.9% |
| Dec 2023 | $34.07B | +6.6% | 15.9% | 4.6% | 3.2% |
| Dec 2022 | $31.97B | +15.1% | 15.0% | 3.7% | 2.5% |
| Dec 2021 | $27.77B | +43.0% | 14.6% | 3.7% | 2.4% |
| Dec 2020 | $19.42B | +15.4% | 18.6% | 5.6% | 3.5% |
| Dec 2019 | $16.83B | -10.9% | 17.4% | 6.2% | 4.4% |
| Dec 2018 | $18.89B | -5.0% | 17.9% | 6.0% | 3.7% |
| Dec 2017 | $19.88B | +11.8% | 11.7% | -2.8% | -2.6% |
| Dec 2016 | $17.78B | N/A | 97.3% | 1.7% | 0.3% |
Income Statement
In the fiscal year ended Dec 2025, net income fell 60.0% from the year before. In the quarter ended Sep 2026, net income fell 51.9% from the same quarter a year earlier.
Annual
| Line item | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 | Dec 2019 | Dec 2018 | Dec 2017 | Dec 2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $45.43B | $40.65B | $34.07B | $31.97B | $27.77B | $19.42B | $16.83B | $18.89B | $19.88B | $17.78B |
| Cost of revenue | $39.49B | $34.43B | $28.67B | $27.18B | $23.70B | $15.82B | $13.90B | $15.50B | $17.57B | $485.00M |
| Gross profit | $5.94B | $6.22B | $5.40B | $4.80B | $4.07B | $3.60B | $2.92B | $3.39B | $2.32B | $17.30B |
| Operating income | $781.00M | $1.71B | $1.57B | $1.17B | $1.02B | $1.08B | $1.04B | $1.13B | -$555.00M | $306.00M |
| Net income | $472.00M | $1.18B | $1.09B | $792.00M | $659.00M | $673.00M | $737.00M | $707.00M | -$512.00M | $52.00M |
| EBITDA | $976.00M | $1.89B | $1.74B | $1.35B | $1.13B | $1.15B | $1.15B | $1.24B | -$284.00M | $519.00M |
Quarterly
| Line item | Sep 2026 | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 | Mar 2024 | Dec 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $11.08B | $10.87B | $10.80B | $11.38B | $11.48B | $11.43B | $11.15B | $10.50B | $10.34B | $9.88B | $9.93B | $9.05B |
| Gross profit | $1.36B | $1.43B | $1.53B | $1.24B | $1.43B | $1.60B | $1.67B | $1.50B | $1.70B | $1.51B | $1.52B | $1.59B |
| Operating income | $106.00M | $145.00M | $83.00M | -$162.00M | $137.00M | $373.00M | $433.00M | $380.00M | $467.00M | $434.00M | $426.00M | $316.00M |
| Net income | $38.00M | $60.00M | $14.00M | -$160.00M | $79.00M | $255.00M | $298.00M | $251.00M | $326.00M | $301.00M | $301.00M | $216.00M |
Balance Sheet
As of Dec 2025, cash and equivalents exceeded total debt of $3.77B by $482.00M.
Annual
| Line item | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 | Dec 2019 | Dec 2018 | Dec 2017 | Dec 2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Total assets | $15.56B | $15.63B | $14.89B | $12.31B | $12.21B | $9.53B | $6.79B | $7.15B | $8.47B | $7.45B |
| Current assets | $12.44B | $12.77B | $12.54B | $10.08B | $10.06B | $7.88B | $5.97B | $6.46B | $7.51B | $5.99B |
| Cash and equivalents | $4.25B | $4.66B | $4.85B | $4.01B | $4.44B | $4.15B | $2.45B | $2.83B | $3.19B | $2.82B |
| Total liabilities | $11.49B | $11.13B | $10.68B | $9.35B | $9.58B | $7.44B | $4.83B | $5.51B | $7.13B | $5.80B |
| Short-term debt | $0 | $15.00M | $20.00M | $41.00M | $35.00M | $2.70B | $18.00M | $241.00M | $653.00M | $472.00M |
| Long-term debt | $3.77B | $2.92B | $2.18B | $2.18B | $2.17B | $2.13B | $1.24B | $1.02B | $1.32B | $975.00M |
| Shareholder equity | $4.07B | $4.50B | $4.21B | $2.96B | $2.63B | $2.10B | $1.96B | $1.65B | $1.34B | $1.65B |
Quarterly
| Line item | Sep 2026 | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 | Mar 2024 | Dec 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total assets | $15.65B | $16.00B | $16.39B | $15.56B | $15.70B | $16.21B | $16.39B | $15.63B | $15.76B | $15.19B | $15.51B | $14.89B |
| Total liabilities | $11.50B | $11.83B | $12.31B | $11.49B | $11.51B | $11.61B | $12.08B | $11.13B | $10.99B | $10.34B | $11.02B | $10.68B |
| Cash and equivalents | $4.48B | $4.99B | $5.31B | $4.25B | $4.22B | $4.50B | $4.86B | $4.66B | $4.73B | $4.35B | $4.51B | $4.85B |
| Shareholder equity | $4.16B | $4.17B | $4.08B | $4.07B | $4.19B | $4.60B | $4.31B | $4.50B | $4.77B | $4.84B | $4.49B | $4.21B |
Cash Flow
Operating cash flow was negative in the fiscal year ended Dec 2025.
Annual
| Line item | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 | Dec 2019 | Dec 2018 | Dec 2017 | Dec 2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating cash flow | -$535.00M | $644.00M | $1.66B | $773.00M | $2.12B | $1.90B | $434.00M | -$314.00M | $804.00M | $673.00M |
| Capital expenditures | $101.00M | $100.00M | $84.00M | $91.00M | $77.00M | $74.00M | $57.00M | $30.00M | $86.00M | $176.00M |
| Free cash flow | -$636.00M | $544.00M | $1.58B | $682.00M | $2.04B | $1.82B | $377.00M | -$344.00M | $718.00M | $497.00M |
| Share repurchases | $1.00B | $1.00B | $0 | $400.00M | $128.00M | $636.00M | $561.00M | $549.00M | $0 | $0 |
| Investing cash flow | $312.00M | -$464.00M | -$744.00M | -$790.00M | -$1.65B | -$400.00M | -$293.00M | $1.14B | -$1.06B | -$206.00M |
| Financing cash flow | -$170.00M | -$347.00M | -$58.00M | -$441.00M | -$183.00M | $217.00M | -$559.00M | -$1.19B | $636.00M | $19.00M |
Quarterly
| Line item | Sep 2026 | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 | Mar 2024 | Dec 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating cash flow | -$159.00M | -$294.00M | $1.08B | -$298.00M | -$125.00M | -$302.00M | $190.00M | -$224.00M | $873.00M | -$219.00M | $214.00M | -$690.00M |
| Capital expenditures | $37.00M | $30.00M | $27.00M | $1.00M | $38.00M | $42.00M | $22.00M | $11.00M | $35.00M | $27.00M | $27.00M | $5.00M |
| Free cash flow | -$196.00M | -$324.00M | $1.05B | -$299.00M | -$163.00M | -$344.00M | $168.00M | -$235.00M | $838.00M | -$246.00M | $187.00M | -$695.00M |
Frequently Asked Questions About MOH
What is Molina Healthcare's annual revenue?
Molina Healthcare reported revenue of $45.43B for the fiscal year ended Dec 31, 2025.
How fast is Molina Healthcare's revenue growing?
Revenue was up 11.7% for the fiscal year ended Dec 31, 2025 compared with the year before. The compound annual revenue growth rate over 3 years was 12.4%.
Is Molina Healthcare profitable?
Yes. Molina Healthcare reported net income of $472.00M for the fiscal year ended Dec 31, 2025, with a net margin of 1.0%.
How much free cash flow does MOH generate?
For the fiscal year ended Dec 31, 2025, operating cash flow of -$535.00M minus capital expenditures of $101.00M produced free cash flow of -$636.00M.
How much debt does Molina Healthcare have?
The balance sheet dated Dec 31, 2025 reported long-term debt of $3.77B, short-term debt of $0 and cash and equivalents of $4.25B.
MOH pages: Overview, Earnings, Forecast, Financials, Valuation, Competitors